Adding Value to your Drug Development Process

Even at very early stage in drug development, the regulatory requirements and marketing strategies have an important impact on procedures. The 4th SBA Academy (November 9, 2011) in Berne features organizations and member companies of the Swiss Biotech Association (e.g. Novartis, Santhera, Preclin, Basilea) giving a hands-on overview on the drug development and regulatory process from drug discovery to clinical phase 1 trials.

Deadline for registration: October 22, 2011. Reduced fee of CHF 90.00 for Memebers of the Swiss Biotech Association, CTI label and project companies and members from academia.